Scott Kellen
2020
In 2020, Scott Kellen earned a total compensation of $489.3K as Chief Financial Officer and Secretary at DiaMedica Therapeutics, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $79,238 |
|---|---|
| Option Awards | $119,140 |
| Salary | $276,075 |
| Other | $14,850 |
| Total | $489,303 |
Kellen received $276.1K in salary, accounting for 56% of the total pay in 2020.
Kellen also received $79.2K in non-equity incentive plan, $119.1K in option awards and $14.9K in other compensation.
Rankings
In 2020, Scott Kellen's compensation ranked 11,082nd out of 13,090 executives tracked by ExecPay. In other words, Kellen earned more than 15.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,082 out of 13,090 | 15th |
Division Manufacturing | 4,737 out of 5,621 | 16th |
Major group Chemicals And Allied Products | 1,966 out of 2,254 | 13th |
Industry group Drugs | 1,719 out of 1,954 | 12th |
Industry Pharmaceutical Preparations | 1,270 out of 1,459 | 13th |
Source: SEC filing on April 5, 2022.
Kellen's colleagues
We found two more compensation records of executives who worked with Scott Kellen at DiaMedica Therapeutics in 2020.
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019